A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).

Methylene dimethane sulphonate (MDMS), the first member of the homologous series of dimethane sulphonic acid esters, was administered to 19 patients with advanced epithelial ovarian cancer. All patients had received prior chemotherapy and in addition 3 had received prior radiotherapy. MDMS was given...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, D. B., Lind, M. J., Kaye, S. B., Newlands, E. S., Blackledge, G. R., Gibson, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246396/
https://www.ncbi.nlm.nih.gov/pubmed/3395557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246396/
https://www.ncbi.nlm.nih.gov/pubmed/3395557

Ejemplares similares